British Journal of Anaesthesia, ISSN 0007-0912, 10/2018, Volume 121, Issue 4, pp. 730 - 738
Cancellation of planned surgery impacts substantially on patients and health systems. This study describes the incidence and reasons for cancellation of...
operating room management | Health Services Research | medical resource utilisation | surgery | NEED | VALIDATION | ANESTHESIOLOGY | CRITICAL-CARE | CANCELLATIONS | ELECTIVE SURGERY
operating room management | Health Services Research | medical resource utilisation | surgery | NEED | VALIDATION | ANESTHESIOLOGY | CRITICAL-CARE | CANCELLATIONS | ELECTIVE SURGERY
Journal Article
2015, ISBN 9781498516921, xiii, 227
Book
2013, ISBN 9780739182048, xii, 231
Book
2012, ISBN 9780803220966, xvi, 516
Book
Chest, ISSN 0012-3692, 08/2009, Volume 136, Issue 2, pp. 396 - 404
CT scan measures of emphysema and airway disease have been correlated with lung function in cohorts of subjects with a range of COPD severity. The contribution...
DIMENSIONS | OBSTRUCTIVE PULMONARY-DISEASE | VOLUME-REDUCTION SURGERY | RESPIRATORY SYSTEM | PHENOTYPE | FLOW LIMITATION | CRITICAL CARE MEDICINE | Multivariate Analysis | Predictive Value of Tests | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Dyspnea - diagnostic imaging | Pulmonary Disease, Chronic Obstructive - physiopathology | Forced Expiratory Volume | Airway Obstruction - diagnostic imaging | Sensitivity and Specificity | Pulmonary Ventilation - physiology | Adult | Female | Pulmonary Disease, Chronic Obstructive - diagnostic imaging | Severity of Illness Index | Pulmonary Emphysema - physiopathology | Risk Assessment | Airway Obstruction - physiopathology | Probability | Dyspnea - physiopathology | Pulmonary Emphysema - diagnostic imaging | Total Lung Capacity - physiology | Analysis of Variance | Aged | Respiratory Function Tests | Cohort Studies | CT imaging | Usage | Lung diseases, Obstructive | Care and treatment | Patient outcomes | Emphysema, Pulmonary | Research | Lung volume measurements | Original Research
DIMENSIONS | OBSTRUCTIVE PULMONARY-DISEASE | VOLUME-REDUCTION SURGERY | RESPIRATORY SYSTEM | PHENOTYPE | FLOW LIMITATION | CRITICAL CARE MEDICINE | Multivariate Analysis | Predictive Value of Tests | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Dyspnea - diagnostic imaging | Pulmonary Disease, Chronic Obstructive - physiopathology | Forced Expiratory Volume | Airway Obstruction - diagnostic imaging | Sensitivity and Specificity | Pulmonary Ventilation - physiology | Adult | Female | Pulmonary Disease, Chronic Obstructive - diagnostic imaging | Severity of Illness Index | Pulmonary Emphysema - physiopathology | Risk Assessment | Airway Obstruction - physiopathology | Probability | Dyspnea - physiopathology | Pulmonary Emphysema - diagnostic imaging | Total Lung Capacity - physiology | Analysis of Variance | Aged | Respiratory Function Tests | Cohort Studies | CT imaging | Usage | Lung diseases, Obstructive | Care and treatment | Patient outcomes | Emphysema, Pulmonary | Research | Lung volume measurements | Original Research
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2018, Volume 36, Issue 2, pp. 240 - 247
Aims A primary objective of this study was to investigate the effect of single and multiple doses of alisertib, an investigational Aurora A kinase inhibitor,...
QTc interval | Oncology | Medicine & Public Health | Alisertib | Pharmacology/Toxicology | Aurora a kinase | MITOTIC KINASES | CELL-DIVISION | ANEUPLOIDY | ONCOLOGY | PHARMACOLOGY & PHARMACY | Pyrimidines - blood | Humans | Drugs, Investigational - therapeutic use | Metabolome | Azepines - blood | Male | Aurora Kinase A - antagonists & inhibitors | Aurora Kinase A - metabolism | Azepines - therapeutic use | Neoplasms - drug therapy | Heart Rate - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Electrocardiography | Pyrimidines - pharmacokinetics | Female | Azepines - pharmacokinetics | Neoplasms - pathology | Antimitotic agents | Complications and side effects | Dosage and administration | Research | Antineoplastic agents | Drug therapy | Cancer | EKG | Echocardiography | Parameters | Pharmacology | Patients | Confidence intervals | Heart rate | Studies | Inhibitors | Upper bounds | Production methods | Pharmacokinetics | Heart diseases | Prolongation | Recorders | Phase I Studies
QTc interval | Oncology | Medicine & Public Health | Alisertib | Pharmacology/Toxicology | Aurora a kinase | MITOTIC KINASES | CELL-DIVISION | ANEUPLOIDY | ONCOLOGY | PHARMACOLOGY & PHARMACY | Pyrimidines - blood | Humans | Drugs, Investigational - therapeutic use | Metabolome | Azepines - blood | Male | Aurora Kinase A - antagonists & inhibitors | Aurora Kinase A - metabolism | Azepines - therapeutic use | Neoplasms - drug therapy | Heart Rate - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Electrocardiography | Pyrimidines - pharmacokinetics | Female | Azepines - pharmacokinetics | Neoplasms - pathology | Antimitotic agents | Complications and side effects | Dosage and administration | Research | Antineoplastic agents | Drug therapy | Cancer | EKG | Echocardiography | Parameters | Pharmacology | Patients | Confidence intervals | Heart rate | Studies | Inhibitors | Upper bounds | Production methods | Pharmacokinetics | Heart diseases | Prolongation | Recorders | Phase I Studies
Journal Article